Vertex Pharmaceuticals’ CRISPR-based therapy made history as the first drug of its type, transforming care options for sickle ...

Treating pain has long been a challenge. Over-the-counter treatments often don’t do enough, while opioids block pain signals ...

Kintsugi powered by Vertex is built for flexibility, designed to integrate with supported financial systems. This approach ensures that businesses can benefit from AI-powered tax automation regardless ...

The platform that makes advanced data science accessible with Graph Neural Networks and Predictive Query Language.

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Forget what you think you know. Our lab tests reveal surprising links between battery life, price, suction and weight.

Over the past six months, Vertex Pharmaceuticals’s stock price fell to $413.23. Shareholders have lost 12.5% of their capital ...

Vertex Pharmaceuticals has been a clear winner in the pharmaceutical sector. Over the past two decades, this powerhouse has ...

FumeFX 7.1 for 3ds Max introduces a faster RenderWarps algorithm, Alembic point cloud support, and viewport improvements for ...

Looking at options history for Vertex Pharmaceuticals (NASDAQ: VRTX) we detected 10 trades. If we consider the specifics of ...

Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release third quarter 2025 financial results before the market opens on Monday, ...